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Abstract: Background. Endoscopic resection followed by
radiotherapy as primary treatment for adenocarcinoma of the
sinuses is emerging as an alternative to open resection.
Methods. A total of 44 patients primarily treated by an en-
doscopic approach followed by radiotherapy from 1992 to
2004 seen at our ENT-Department were analyzed for outcome
and prognostic factors.
Results. Median follow-up was 61 months. Median follow-
up of the patients alive at the end of the follow-up period was
100 months. For the 5-year follow-up, the overall survival, dis-
ease-specific survival, and recurrence-free survival were 63%
(7% SE), 82% (6), and 60% (8%), respectively. The over-
all survival, disease-specific survival, and recurrence-free sur-
vival after 100 months of follow-up were 53% (8%), 72%
(9%), and 54% (9%), respectively. Four factors significantly
influenced the disease-specific survival.
Conclusion. This study of a homogeneous cohort of
patients with sinonasal adenocarcinoma treated by endoscopic
resection and radiotherapy confirms that endoscopic resection
is a valid alternative to open resection. VC 2010 Wiley Periodi-
cals, Inc. Head Neck 00: 000–000, 2010
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The first reports on endoscopic surgery as an
exclusive approach or in combination with an
external approach for the treatment of malig-
nant tumors of the nose and sinuses emerged in
the late 1990s.1,2 Previous series of malignant
tumors of the sinonasal tract treated with an
endoscopic approach often included a diversity
of histologic subtypes and treatment protocols.
The cohorts were very small, due to the rarity of
the pathology and the long natural history.3–7 In
Belgium, malignancies of the sinuses account
for only 3% of the overall head and neck oncol-
ogy diagnoses.8,9
In the last 2 years, studies with larger
cohorts, more homogeneous histology, and treat-
ment protocols were published reporting good
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local control of disease and survival after endo-
scopic resection.10,11 However, the relatively
short follow-up and the difference in patient
selection made it difficult to compare with the
established gold standard of craniofacial resec-
tion (CFR) or lateral rhinotomy with medial
maxillectomy followed by radiotherapy.12,13
PATIENTS AND METHODS
We reviewed a series of 44 patients with previ-
ously untreated adenocarcinoma of the ethmoid
undergoing endoscopic resection and radiother-
apy between 1992 and 2004 in our center. The
results after 3 years of follow-up have already
been published by Bogaerts et al.14 The same
group of patients were now analyzed with lon-
ger follow-up periods. This homogeneous cohort
of patients with sinonasal adenocarcinoma
treated by endoscopic resection and postopera-
tive radiotherapy has the longest follow-up pe-
riod reported. In addition, we performed an
analysis on the frequencies of the different sites
of origin of this tumor and investigated more in-
depth the professional background of the
patients in the cohort, to further document the
earlier described etiologic role of occupational
exposure to wood dust, as patients in our region
often seemed to have worked in the flourishing
wood industry in the region of our center.15–17
The correlation with the leather industry could
not be analyzed due to the absence of this indus-
try in our region.
Diagnostic Workup. The preoperative diagnostic
workup consisted of a histopathological examina-
tion of an endoscopic biopsy specimen, with confir-
mation after surgery. Preoperative imaging
included a dedicated multiplanar MRI study with
injection of gadolinium for 40 patients (91%), and
all patients underwent a dedicated CT study with
contrast agent injection. On the basis of this imag-
ing, all tumors were staged according to the 2002
American Joint Committee on Cancer staging sys-
tem.18 Routine blood tests, chest x-rays, and ab-
dominal ultrasound scans were performed to
evaluate the presence of regional and distant me-
tastasis. Informed consent was obtained from all
patients prior to any testing.
Selection Criteria for Endoscopic Resection. The
status of all patients in the study were discussed
during a multidisciplinary team meeting. Manage-
ment options, including the possibility of requiring
a CFR, were discussed along with factors related to
the patients’ general health and comorbidity. Pre-
operative imaging was crucial in the decision-mak-
ing process.
The indications have been extended during the
last years. Endoscopic resection was chosen when
no invasion of dura, brain, or orbita was shown on
preoperative CT or MRI scans, with the exception
of some T4b lesions showing limited dural invasion
that also were treated endoscopically.
Surgical Technique. An endoscopic resection of
the tumor was performed with the patient
under general anesthesia by 1 of the senior staff
surgeons. For T1 tumors, the technique used
can be described as an ‘‘en bloc’’ resection. After
removal of the surrounding non-diseased struc-
tures for optimal approach, the small tumor was
mobilized to allow a view of its insertion site
and then removed in 1 piece. The majority of
the tumors were mid-sized (T2) and were
removed by a ‘‘phased’’ resection. This method
consisted of a preparatory phase in which the
tumor bulk was visualized. Using atraumatic
suction, the insertion site of the tumor was
defined as precisely as possible. The next step
consisted of removing the tumor bulk using cold
instruments and, lately, a microdebrider. In the
last step, the tumor origin was broadly circum-
scribed by standard complete and radical fronto-
spheno-ethmoidectomy, including a large middle
meatal antrostomy and a resection of the upper
third of the septum with a margin of about 1 cm
where possible. For larger tumors (T3–T4),
there was no option other than ‘‘piecemeal’’ re-
moval, followed by an ‘‘en bloc’’ fronto-spheno-
ethmoidectomy and resection of the superior
part of the nasal septum. If the tumor was uni-
lateral, no contralateral radical surgery was
undertaken. In cases of limited dural invasion,
an endoscopic reconstruction was performed on
the level of the roof of the ethmoid by a multi-
layer closure technique using fascia and
mucosa.
Separate histological analyses were done on
all mucosal resection borders and cribriform
plate. Only in doubt, a frozen section biopsy con-
trol was performed.
Postoperative Radiotherapy. All patients had
postoperative radiotherapy planned, generally
starting within 5 weeks after surgery. Thirty-
one patients received 3-dimensional (3D)-confor-
mal radiotherapy applying a 3-field photons
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technique, using a once-daily fractionation
scheme with a median dose of 60 Gy (range, 50–
70 Gy) in 30 fractions. Fields were defined by
extension of the lesion and by aid of a planning
CT scan. Eight patients received intensity —
modulated radiotherapy (IMRT). One patient
refused radiotherapy, 1 patient’s radiotherapy
was discontinued due to intercurrent disease,
and in another patient radiotherapy was
stopped due to the development of lung
metastases.
Statistical Analysis. The Statistical Package for
Social Sciences (SPSS, version 15.0, Chicago,
IL), commercially available, was used for statis-
tical analysis. The overall survival, disease-spe-
cific survival, and recurrence-free survival rates
were calculated by the Kaplan–Meier method.19
Univariate comparisons between groups were
performed using the log-rank test. A value of p 
.05 was considered statistically significant.
All clinical data, surgical reports, preopera-
tive and postoperative images, data on adjuvant
therapy, and follow-up information were col-
lected retrospectively. Variables evaluated for
prognostic significance are reported in Table 1.
Follow-Up. Postoperative follow-up of the onco-
logic status consisted of clinical endoscopic ex-
amination of the nasal cavity every 2 months
during the first year, every 4 months during the
second year, every 6 months during the third
year, and every 8, 10, and 12 months during the
fourth, fifth, and sixth years, respectively, and
then yearly thereafter. Additional imaging was
only performed when a clinically suspicious
lesion was endoscopically detected.
RESULTS
The study group included 44 patients, 43 men
and 1 woman, with a mean age of 62 years at
diagnosis. Presenting symptoms were unilateral
rhinologic symptoms, with no predominant side.
The T classification, according to the 2002
American Joint Committee on Cancer staging
system, is reported in Table 2.
All T4a tumors showed sphenoidal sinus
involvement, whereas all T4b tumors showed
erosion of the cribriform plate with dural inva-
sion. Metastatic disease in the neck or at distant
sites was not diagnosed at first diagnosis in any
of the 44 patients.
All resection specimens were adenocarcino-
mas of the intestinal-type. At surgery and con-
firmed by histopathological examination, the
tumor was found to involve the sites as shown
in Figure 1. The olfactory cleft, as described in
the study by Jankowski et al15 (middle and
superior turbinate, posterior septum, and cribri-
form plate), was involved in 84% of all cases.
The site of recurrence most often included
the posterior ethmoid cells (21%), the ethmoid
roof (14%), and the posterior septum (11%).
It is interesting to note that, except for 1
patient for whom no information was available,
42 of the remaining patients had an exposure to
wood dust in their history.
Follow-up, ranging between 1 and 161 months
(mean, 68 months; median, 61 months), was avail-
able for all patients. Follow-up of the patients alive
at the end of the follow-up period ranged between
19 and 154 months (mean, 89 months; median, 100
months). Eleven patients died of causes unrelated
to their tumors.
The 5-year overall survival was 63% (7%
SE; Figure 2), with 72% (9%) for T2 tumors,
60% (22%) for T3 tumors, and 42% (14%) for
T4 tumors.
The 1 patient with a T1 lesion is still alive
after 8 years 5 months of follow-up. The overall
survival after 100 months of follow-up was 53%
(8%).
Table 2. T classification.
T classification No. of patients
T1 1
T2 26
T3 5
T4a 9
T4b 3
Table 1. Identified prognostic factors for different outcomes.
Prognostic factors
Overall
survival
Disease-
specific
survival
Recurrence-
free
survival
Clinical tumor characteristics
T classification .468 .947 .292
T1–T2 vs T3–T4 .156 .953 .978
Recurrence
First local recurrence .973 .025 –
Second local recurrence .458 .002 <.0001
Development of metastasis
Regional .074 .003 .001
Distant .056 <.0001 <.0001
Note: p values according to the log-rank test.
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The 5-year disease-specific survival was 82%
(6%), with 83% (8%) for T2 tumors, 75%
(22%) for T3 tumors, and 80% (13%) for T4
tumors (Figure 3). The 100-month disease-spe-
cific survival was 72% (9%).
The mean recurrence-free interval, determined
as the time between the day of surgery and the
date of diagnosis of the first recurrence, was 27
months (5). The 5-year recurrence-free survival
was 60% (8%). The recurrence-free survival after
100 months of follow-up was 54% (9%). As in the
study by Bogaerts et al,14 there was still no statis-
tically significant influence of T classification on
overall survival (log-rank p ¼ .468), disease-spe-
cific survival (log-rank p¼ .947), or on local control
(log-rank p ¼ .292).
Sixteen of 44 patients (36%) presented with a
local recurrence. There was a statistically signifi-
cant influence of recurrence on the disease-specific
survival (log-rank p ¼ .025; Figure 4).
The treatment protocols of the recurrences are
reported in Table 3. Six of these remained free of
tumor recurrence throughout the follow-up period.
Ten patients presented with a second recurrence at
a later date. There was a statistically significant
influence of second recurrence on the disease-spe-
cific survival (log-rank p ¼ .002) and the recur-
rence-free survival (log-rank p ¼ < .0001). Seven of
the patients with a second recurrence were again
treated by surgery, while the other 3 patients
received supportive care only (Table 3). Distant
FIGURE 1. Subsites of tumor involvement percentages. [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 2. Overall survival of the whole group. [Color figure
can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 3. Disease-specific survival of the T-subgroups. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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metastasis occurred in 7 patients, in 2 to the lungs,
in 1 to the brain, and in 1 to the spine. Three
patients had multiple metastases. Neck metastasis
occurred in 2 patients who developed distant me-
tastasis as well.
There was a statistically significant influence of
the development of neck metastasis (log-rank p ¼
.003) and distant metastasis (log-rank p ¼ < .0001)
on the disease-specific survival and recurrence-free
survival (log-rank p ¼ .001 and log-rank p ¼ <
.0001, respectively).
DISCUSSION
Comparison to Open Resection. In evaluating
outcome, endoscopic approaches should be com-
pared with traditional external techniques: on 1
side with lateral rhinotomy for tumors not
reaching the anterior skull base and on the
other side with CFR for tumors in contact with
or invading the anterior skull base.4,5 Because
of the rarity of good studies on lateral rhinot-
omy, comparison is very difficult. In contrast,
however, there are several reports of large
patient cohorts treated with CFR with a long
follow-up available in the literature. Howard et
al,20 analyzing 308 patients treated with CFR
with a follow-up of up to 25 years, showed a 5-
year disease-free survival of 59% for malignant
tumors and 58% for adenocarcinomas specifi-
cally. In our series, the overall survival, disease-
specific survival, and recurrence-free percen-
tages were 63% (7% SE), 82% (6), and 60%
(8%), respectively. It is worth mentioning that
an important part of our group of patients (39%)
had a T3 or T4a to T4b lesion.
In contrast with previous studies4,7,10 with
relatively shorter follow-up time, the present
study has sufficient follow-up to meaningfully
compare the outcome of endoscopic resection to
the established gold standard of CFR followed
by radiotherapy. Equal survival and disease-spe-
cific survival curves are found for the 2 treat-
ment protocols.
Table 3. Overview of the 16 recurrences and their treatment and their final follow-up status.
Date of
1st surgery
T
classification
Type
of surgery RT
Date
1st R
Treatment
1st R Date 2nd R
Treatment
2nd R
Neck
M
Distant
M
FU
status
Date of
death
Jun/93 T2 ER R 50 Gy Aug/97 ER R / / N N DOC Nov/06
Oct/94 T2 ER L 50 Gy Oct/95 ER R Dec/96 SC N N DOD Mar/99
Dec/95 T4b ER R 60 Gy Dec/96 CFR / / N Lung AWD /
Apr/98 T2 ER L 60 Gy Apr/04 ER R Dec/04 ER L N N DOD Sep/05
Oct/98 T2 ER R 60 Gy Apr/03 ER R Jun/08 CFR N N NED /
Jun/99 T2 ER R 60 Gy Nov/99 ER R þ CFR Apr/00 SC N Multiple DOD Jul/00
Dec/99 T1 ER R 60 Gy Feb/01 ER R / / N N NED /
Jun/00 T3 ER R 60 Gy Jan/03 ER R Aug/06 CFR N Lung AWD /
Jul/00 T2 ER R 60 Gy Sep/02 RS / / N N DOC Mar/04
Oct/99 T2 ER L 60 Gy Feb/01 CFR Sep/02 ER R N N NED /
Oct/01 T4b ER L 60 Gy Dec/02 CFR Nov/03 SC N Spine DOD Dec/03
Sep/02 T2 ER R 70 Gy May/07 ER: debulking (3) / / N Brain DOD Sep/08
Feb/03 T3 ER L 66 Gy Apr/04 ER L Apr/06 ER L P Multiple DOD Nov/07
May/03 T4a ER R þ ER L 60 Gy Jan/04 ER Mar/05 ER N N NED /
Mar/04 T2 ER R 56 Gy Mar/08 ER R Sep/08 ER R N N NED /
Jul/04 T2 ER L 60 Gy Apr/05 MRND L / / P Multiple DOD Nov/06
Abbreviations: RT, radiotherapy; R, recurrence; M, metastases; FU, follow-up; ER R, endoscopic surgery at the right side; Gy, Gray; N, negative; DOC,
death other cause; ER L, endoscopic surgery at the left side; SC, supportive care; DOD, death of disease; CFR, craniofacial resection; AWD, alive with
disease; NED, no evidence of disease; RS, resection of septum þ ossa nasalia and skin with reconstruction; P, positive; MEND L, modified radical
neck dissection (left side).
FIGURE 4. Disease-specific survival: recurrence versus no re-
currence. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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Besides comparable survival curves for both
surgical techniques, other factors can play an im-
portant role to promote endoscopic resection as a
promising alternative technique to open surgery.
Factors that favor the use of endoscopic resection
are avoidance of facial incisions and osteotomies,
short hospitalization, and a very low morbidity.21
Even in the hands of experts, CFR is still associ-
ated with rates of mortality (4.7%) and morbidity
(36.3%) that must be considered, as published by
Ganly et al.22
Endoscopic resections are associated with a
lower rate of complications even in cases requir-
ing dura resection (radiological T4b in our series).
In fact, overall we observed no major complica-
tions associated with endoscopic resection.
Although there are a lot of advantages to treat
an adenocarcinoma of the sinuses with an endo-
scopic resection, there are limitations as well.
There is the debate about obtaining clear mar-
gins when resecting a tumor and subsequently
about the limits of an endoscopic approach. Gen-
erally, we can state that anatomy dictates where
adequate margins can be obtained, especially to-
ward the anterior skull base.
Piecemeal resection as an alternative to ‘‘en
bloc’’ resection seems contradictory to the corner-
stone of oncological surgery that focuses on a
maximal in 1 piece resection, avoiding the risk of
tumor spilling.23 But no data supporting this hy-
pothesis in malignant paranasal sinus disease
were published, and en bloc resection using exter-
nal approaches is also frequently impossible.
Comparison to Other Studies using Endoscopic
Resection. There is a general consensus in the
literature that more homogeneity in histology
and treatment protocols is necessary to compare
the survival curves in a meaningful way. To
date, Bogaerts et al14 had the most homogene-
ous group. Another problem is the small patient
cohorts included in the studies making it diffi-
cult to identify statistically significant factors
influencing oncological outcome. However, the
recent study of Nicolai et al10 and Choussy
et al11 are exceptions of this remark (Table 4).
Comparing our findings with those of Nicolai
et al7,10 and Lund et al,4 it is remarkable that
they have more intense postoperative follow-up
schemes by imaging and endoscopic examina-
tions. Nicolai et al7,10 has smaller intervals for
detection of recurrence: 10 months and 15
months, respectively, in their last 2 studies, in
comparison with 25 months in our previous
study.14 Their more intense follow-up schemes
with imaging can explain their smaller intervals
for detection of recurrence. However, this did
not change the percentage of recurrences
because long-term follow-up was available.
The study by Lund et al4 did not report on
their recurrence-free interval.
In our study, local recurrences are more fre-
quent than distant metastases, and the local recur-
rences are responsible for the majority of deaths.
Postoperative Radiotherapy. The limitations of
surgery alone are obvious given the frequent
presentation of advanced disease. Postoperative
radiotherapy improves local control regardless
of surgical margins.25 At our center, patients
with sinonasal cancer have been treated for
many decades with the combination of surgery
and radiotherapy (RT).
Since 2003, IMRT has been routinely used at
our center for the treatment of sinonasal cancer.
IMRT allows sparing of normal tissues in con-
trast with conventional or even 3D-conformal
RT which is associated with, especially in these
cases, visual toxicity.26 Recently, several studies
confirmed that besides the low risk of complica-
tions with IMRT, IMRT has similar local control
Table 4. Comparison to the literature.
Study No. of patients % Adenoca 5-y OS 5-y DSS 5-y RFS Mean Fu, mo Treatment
Howard 200620 259 20% 65% 59% – 63 CFR
Lund 20074 49 31% 83% – 72% 36 EEA  RT
Nicolai 20077 16 75% – 93% 87% 47 EEA  RT
Choussy 200811 478 100% 64% – – 58.7 1.5% EEA  RT
Nicolai 200810 184 37% – 94% – 34 EEA (73%) or CEA (27%)  RT
Bogaerts 200814 44 100 83 83 62 42 EEA þ RT
Hanna 200924 120 14 76 87 85 37 EEA (77.5%) or CEA (22.5%)  RT
This study 44 100 63 82 60 68 EEA þ RT
Abbreviations: OS, overall survival; DSS, disease-specific survival; RFS, recurrence-free survival; FU, follow-up time in months; CFR, craniofacial resec-
tion; EEA, exclusive endoscopic approach; RT, radiotherapy; CEA, cranio-endoscopic approach.
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and survival rates as conventional RT or 3D-
conformal RT techniques.27,28
Prognostic Factors in Ethmoid Adenocarcinomas. As
in the study by Bogaerts et al,14 there was still
no statistically significant influence of T classifi-
cation on overall survival, disease-specific sur-
vival, or recurrence-free survival. Even when
the small tumors (T1–T2) and the T3 to T4
lesions were grouped, no influence (Table 1)
could be proven. This could be due to lack of sta-
tistical power (Figure 5).
Choussy et al11 published a study about
patients with exposure to wood or leather who were
found to have a better prognosis. In this series, we
had only 1 patient without exposure to wood dust,
therefore, we could not verify this factor.
There was only 1 study11 capable of finding fac-
tors significantly associated with the survival rate
of adenocarcinomas of the sinuses. Given the large
study population of 418 patients, statistical power
to find these factors was sufficient. Factors influ-
encing survival were predominantly the size of the
lesion (T4), extension to the lymph nodes, and in-
tracranial involvement. Surprisingly, development
of distant metastasis could not be shown to have a
statistically significant impact on survival.
In our current series, 7 patients developed me-
tastasis, which significantly influenced the dis-
ease-specific survival (p ¼ < .0001), and
recurrence-free survival (p ¼ < .0001), a first and
a second recurrence also influenced the disease-
specific survival (p ¼ .025 and p ¼ .002, respec-
tively), although this was not surprising, this had
not been described before. We could confirm that
extension to the lymph nodes significantly influ-
enced the disease-specific survival (p ¼ < .0001)
and the recurrence-free survival (p ¼ < .0001).
CONCLUSION
In this homogeneous cohort of patients with eth-
moidal adenocarcinoma treated by endoscopic
resection and postoperative radiotherapy and
with a solid follow-up of 100 months, the 5-year
disease-specific survival of 82% (6%) confirms
that this approach, when properly planned and
performed by experienced surgeons, is an effec-
tive alternative to open approaches.
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